A large surveillance study suggests that an extra pneumococcal vaccine dose for new care home residents can significantly ...

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

"Vaccines are a safe and effective way that individuals can protect themselves, their families and our community against many ...

The Department of Health and Human Services under Robert F. Kennedy Jr. has taken unprecedented steps to change how vaccines ...

Required vaccines include diphtheria, tetanus and pertussis (DTaP), polio, varicella (chickenpox), hepatitis B, meningococcal ...

The quadrivalent meningococcal CRM 197 -conjugate vaccine MenACWY-CRM (Menveo, Novartis Vaccines and Diagnostics, Inc., Cambridge, MA) is licensed in more than 60 countries worldwide for use.

Since the rollout of the conjugate MenC vaccine in 2001 and the MenACWY in 2018, rates of invasive meningococcal disease have dropped dramatically, from 684 cases in 2002, to 136 cases in 2024.

Meningococcal Cases Rise: Symptoms, Vaccine Guide Two Tasmanian women have been hospitalised with invasive meningococcal disease , bringing the number of cases nationally so far this year to 48 .